Bio-Techne (TECH) Free Cash Flow Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.84% |
| Dec 31, 2025 | -0.35% |
| Sep 30, 2025 | -16.60% |
| Jun 30, 2025 | 27.76% |
| Mar 31, 2025 | -5.06% |
| Dec 31, 2024 | 6.78% |
| Sep 30, 2024 | 12.76% |
| Jun 30, 2024 | 5.38% |
| Mar 31, 2024 | 13.19% |
| Dec 31, 2023 | 10.22% |
| Sep 30, 2023 | 5.37% |
| Jun 30, 2023 | 4.22% |
| Mar 31, 2023 | 16.41% |
| Dec 31, 2022 | 12.15% |
| Sep 30, 2022 | 3.37% |
| Jun 30, 2022 | 14.66% |
| Mar 31, 2022 | 22.54% |
| Dec 31, 2021 | 18.56% |
| Sep 30, 2021 | 11.98% |
| Jun 30, 2021 | 26.93% |
| Mar 31, 2021 | 13.38% |
| Dec 31, 2020 | 18.26% |
| Sep 30, 2020 | 16.45% |
| Jun 30, 2020 | -1.92% |
| Mar 31, 2020 | 9.22% |
| Dec 31, 2019 | 11.38% |
| Sep 30, 2019 | -0.52% |
| Jun 30, 2019 | 4.32% |
| Mar 31, 2019 | 2.52% |
| Dec 31, 2018 | 8.68% |
| Sep 30, 2018 | 4.15% |
| Jun 30, 2018 | 19.09% |
| Mar 31, 2018 | -7.40% |
| Dec 31, 2017 | 7.33% |
| Sep 30, 2017 | 8.07% |
| Jun 30, 2017 | 4.39% |
| Mar 31, 2017 | -8.57% |
| Dec 31, 2016 | 16.29% |
| Sep 30, 2016 | -6.31% |
| Jun 30, 2016 | 0.12% |
| Mar 31, 2016 | 1.53% |
| Dec 31, 2015 | 3.22% |
| Sep 30, 2015 | -2.81% |
| Jun 30, 2015 | -0.30% |
| Mar 31, 2015 | 3.42% |
| Dec 31, 2014 | 4.11% |
| Sep 30, 2014 | 2.33% |